IP Library › Assignment 033552/0639
Patent Assignment
Reel/Frame 033552/0639

Corrective Assignment to Correct the Title Listed in the Original Assignment Document Previously Recorded on Reel 030799 Frame 0678. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2014-08-06 Pages: 5
Assignors
MCWHIRTER, JOHN
Executed: 2013-05-21
MACDONALD, LYNN
Executed: 2013-05-22
MURPHY, ANDREW J.
Executed: 2013-06-25
Assignee
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD, TARRYTOWN,, NEW YORK, 10591-6707
Covered Properties (3)
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
Patent: 9,334,334 →
Application: 13/832,247 →
Publication: US 2013/0247234
Histidine Engineered Universal Light Chain Antibodies
Application: 61/611,950 →
Histidine Engineered Universal Light Chain Antibodies
Application: 61/736,930 →
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 15, 2013
From: MCWHIRTER, JOHN; MACDONALD, LYNN; MURPHY, ANDREW J.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 030799/0678 →